JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hovav, E.
Right arrow Articles by Weinstock, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hovav, E.
Right arrow Articles by Weinstock, M.

Temporal factors influencing the development of acute tolerance to opiates

E Hovav and M Weinstock

The present study investigated the influence of the extent of drug effect, duration of action and dose interval on the development of acute tolerance to the respiratory and cardiovascular depressant effects of opiates. Morphine (2, 4 and 10 mg/kg i.v.) caused a dose- related reduction in heart and respiratory rates and elevation in PaCO2 which lasted 4 to 4.5 hr. Acute tolerance occurred to the effect of a second dose of 4 or 10 mg/kg but not 2 mg/kg given 4 hr after the first. When the duration of action of the opiate was limited to 75 min by injection of naloxone (0.125 mg/kg) or by the use of a short acting opiate, fentanyl (0.025 mg/kg), tolerance to a second dose of drug still developed provided it was given at least 4 hr later. When naloxone was given at the peak of the morphine effect (30 min) tolerance did not occur. It is concluded that the development of acute tolerance to opiates depends on the degree of initial drug effect and the time of receptor occupancy. The latter must be longer than that required to attain a peak response. A time period of about 4 hr appears to be necessary for the full development of the biochemical processes involved in this phenomenon.

Volume 242, Issue 1, pp. 251-256, 07/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. J. Bertz, P. D. Kroboth, F. J. Kroboth, I. J. Reynolds, F. Salek, C. E. Wright, and R. B. Smith

J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1317 - 1329.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. M.-C. Ouellet and G. M. Pollack
Pharmacodynamics and Tolerance Development During Multiple Intravenous Bolus Morphine Administration in Rats
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 713 - 720.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics.